The National Institutes of Health this month awarded more than $800,000 in research funding to support the work of four researchers, including two that have collaborated with Regulus Therapeutics, who are examining the role of microRNAs in various aspects of cardiovascular disease.

The first grant was awarded to New York University School of Medicine's Kathryn Moore to fund her work into miRNAs as physiological and pathological regulators of cholesterol homeostasis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.